Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Hunan Warrant Pharmaceuticals patents Bcr-Abl1 and/or BTK inhibitors

March 15, 2021

Targeting membrane protein starves pancreatic tumors

March 15, 2021

Genfleet Therapeutics presents GTPase KRAS mutant inhibitors

March 12, 2021

BeiGene discloses MAP4K1 inhibitors

March 12, 2021

Enrollment opens in phase III trial of [177Lu]PNT-2002 for metastatic CRPC

March 12, 2021

FDA approves Fotivda for relapsed or refractory advanced RCC

March 11, 2021

Dosing initiates in first-in-human study of IMP-7068 in advanced solid tumors

March 11, 2021

Novartis identifies new NSD2 inhibitors

March 11, 2021

Bristol Myers Squibb discloses new IRAK-4 inhibitors

March 11, 2021

PI3K inhibitor umbralisib shows clinical activity in patients with indolent non-Hodgkin's lymphoma

March 10, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...